The adult bone marrow contains a population of multipotent mesenchymal stromal cells (MSCs), defined by plastic adherence, expression of stromal cell surface markers, and differentiation into mesenchymal lineages. There has been much interest in the possible therapeutic use of MSCs in the treatment of demyelinating diseases of the central nervous system. One therapeutic possibility is that these cells may be able to remyelinate when directly injected into the demyelinated spinal cord. Here we examine the effects of direct transplantation of green fluorescent protein (GFP)-labeled MSCs into a model of focal spinal cord demyelination induced by ethidium bromide. We demonstrate that direct intralesional injection of undifferentiated MSCs does not lead to remyelination. Furthermore, we report that transplanted MSCs migrate into areas of normal tissue, deposit collagen, and are associated with axonal damage. These findings support the need for further experimental evaluation of the safety and efficacy of direct parenchymal injection of MSCs into demyelinated lesions and highlight an important issue regarding potential clinical consequences of culture heterogeneity of MSCs between centers.
INTRODUCTION
tory properties (17, 19, 21, 31) . A number of studies have reported in vitro and in vivo differentiation of MSCs into neuronal cells (17, 34) and Schwann cells (19) as The bone marrow contains a well-characterized mesenchymal stromal cell (MSC) population (27) . These well as cardiomyocytes and hepatocytes (17, 31) . However, interpretation of these findings may be confounded cells, also called mesenchymal stem cells or marrow stromal cells, are expanded in vitro as plastic adherent by alternative explanations such as cellular fusion (33). Against this background, a series of reports has sug-monolayers in serum-containing media and can be differentiated into mesenchymal cell types such as osteo-gested that bone marrow-derived cells are able to remyelinate the demyelinated spinal cord (1,2,15,30), a find-cytes, adipocytes, and chondrocytes (10, 13, 27) . They maintain a stable phenotype over 40-50 population dou-ing of potential relevance to multiple sclerosis (6, 8) .
These studies have shown that acutely isolated bone blings. MSCs express stromal cell surface markers including CD90, CD44, and CD105 and do not express marrow (1, 15, 30) and cultured marrow stromal cells (2) can remyelinate axons when injected intravenously or the hematopoetic markers CD45 or CD34 (10).
MSCs are attractive candidates for cell-based thera-directly into a focal demyelinating lesion induced by ethidium bromide in X-irradiated tissue (X-EB lesion). pies because of their comparative ease of isolation, expansion, and potential autologous application. MSCs display In this model, demyelination is induced by focal injection of ethidium bromide and endogenous remyelination a number of potential mechanisms of therapeutic action (10, 13, 20, 21, 24, 25, 27) . These include a broad differenti-is suppressed by X-irradiation-mediated depletion of oligodendrocyte precursor cells. Consequently, any remy-ation repertoire, trophic support, and immunomodula-866 HUNT ET AL. elination observed following transplantation can be at-
The resulting cells were resuspended in low-glucose DMEM and 10% FCS and were plated in T25 culture tributed to the transplanted cells (4). These results raise the possibility of the use of MSCs as remyelinating cells.
dishes. The medium was changed at 48 h and floating cells removed. The stromal layer grew out from adherent A fundamental question in the development of novel cell therapies is the route of delivery of cells. Mesenchy-cells and subsequently grew as a monolayer. The cells were passaged using 0.1% trypsin/EDTA at 80% conflu-mal stromal cells may be administered systemically by intravenous infusion, intrathecally, or focally into a de-ence and replated at a density of 1:3. The cells were characterized at passage 5. Passage 5 cells for transplan-myelinated lesion. However, there is limited data upon which to base assessment of the safety and efficacy of tation were removed from the flasks with trypsin, washed twice in PBS, and resuspended in DMEM at a these different approaches. Further difficulty arises because different populations of MSCs have been used in concentration of 5000 cells/µl. Cell viability was assessed using trypan blue and hemocytometer after tryp-both experimental and clinical settings. Experimental studies of the behavior of bone marrow-derived stromal sinisation with >99% viability. cells in a demyelinated environment have used bone Characterization of Rat Bone Marrow MSCs marrow stromal cells isolated and cultured in media specialized for the growth of neural progenitor cells with GFP fluorescence was analyzed using a FACSCalibur machine (Becton-Dickinson). The phenotype of the ex vivo culture of cells with EGF and FGF-2 (2). In contrast, most clinical studies to date have used MSCs stromal cells was confirmed by immunocytochemical analysis. Cells were plated on PDL/laminin-coated cov-isolated and expanded in basal media (typically lowglucose DMEM) and 10% FCS (9,10) without the addi-erslips. They were washed in PBS and fixed with 4% paraformaldehyde for 15 min at room temperature. Cells tion of growth factors. It is possible that different culture conditions lead to heterogeneity of both culture-initiat-were washed, blocked, and permeablized with 5% normal goat serum (NGS), 0.1% Triton/PBS for 30 min. ing cells and subsequent in vitro and in vivo behavior of MSCs. The problem of MSC heterogeneity has re-Primary antibodies were incubated overnight at 4°C with 2% NGS. Primary antibodies used were fibronectin cently been addressed by a working party of the International Society for Cellular Therapy (ISCT), which has
(1:800 rabbit polyclonal, Sigma), CD90/Thy1 (mouse monoclonal clone MRC OX-7 Abcam Ltd, Cambridge), proposed minimal criteria for the definition of multipotent mesenchymal stromal cells (10). These include: (i) CD34 (Serotec mouse monoclonal), CD45 (1:400, Leucocyte common antigen; Serotec, Oxford, UK) Negative plastic adherence in standard culture conditions, (ii) expression of stromal cell surface markers and absence of controls with omission of primary antibody were performed for all immunocytochemical experiments. defined cell surface markers such as hematopoetic markers, and (iii) functional differentiation of cells into mes-Functional differentiation into adipogenic and osteogeneic lineages was assessed according to established enchymal lineages.
There are no reports of the effects of direct transplan-protocols (16) . Briefly, cells were plated at a density of 3.7 × 10 4 cells/cm 2 on coverslips coated with poly-D-lysine tation of bone marrow-derived MSCs, cultured and characterized according to the principles of the ISCT criteria, and fibronectin (1 µg/ml). Cells were differentiated for 14 days in the following media: adipogenic media con-into an area of focal demyelination. We therefore sought to investigate the remyelinating potential of such MSCs taining αMEM, 10% FCS, 1% penicillin-streptomycin with adipogenic supplement (R&D Systems) containing following focal transplantation into the adult X-EB model of demyelination.
hydrocortisone isobutylmethylxanthine and indomethacin. Cells were also differentiated for 14-21 days in os-MATERIALS AND METHODS teogenic media containing αMEM, 10% FCS, 1%peni-
Isolation of Rat Bone Marrow Mesenchymal cillin-streptomycin with osteogenic supplement (R&D Stromal Cells
Systems) containing dexamethasone, ascorbate-phosphate, and β-glycerolphosphate. The presence of adipocytes Whole bone marrow was removed from the long bones of an adult Sprague-Dawley rat, which expressed was confirmed by phase contrast microscopy with the appearance of lipid droplets. Coverslips were fixed at green fluorescent protein (GFP) under the control of chicken actin promoter (26) (kind gift, M. Okabe, Uni-day 14 for 20 min with fresh 4% paraformaldehyde. Cells were incubated overnight with the following anti-versity of Osaka), using a heparinized 23-gauge needle (2,16). Bone marrow aspirate was diluted in 5 ml of bodies: 10 µg/ml goat anti-mouse fatty-acid binding protein (FABP-4) and10 µg/ml mouse anti-osteocalcin. Cal-DMEM and was loaded onto a 10-ml Ficoll solution using a Pasteur pipette. The cells were centrifuged at 560 × cium deposition in osteocyte cultures was visualized with Alizarin red staining. g for 25 min and collected from the mononuclear layer. (1:3000, Sternberger, CA, USA), monoclonal mouse ium bromide (EB). Briefly, a laminectomy was per-SMI 32 antibody (1:1000, Sternberger, CA, USA), formed at the level of T13 vertebra and the spinal cord monoclonal human anti-fibronectin (1:800, Sigma, Gilexposed. Using a micromanipulator, a Hamilton syringe lingham, Dorset, UK), monoclonal mouse anti-CNPase tipped with a fine glass micropipette was introduced into
(1:100, Sigma), monoclonal p75 (1:100, Chemicon), the dorsal funiculus to a depth of 0.75 mm and 1 µl of polyclonal rabbit anti-S100 (1:200, DAKO), and mono-0.1% EB injected. To abolish the inherent capacity of clonal rat anti-CD45 (1:400, Leucocyte common antithe spinal cord to generate remyelinating cells, the degen; Serotec). All sections were rinsed and then myelinating lesion was induced in tissue that was exincubated for 2 h with the relevant biotinylated (1: posed to 40 Gy of X-irradiation 1 day after EB injection, 200, Vector Laboratories, Peterborough, UK; Southern a procedure that causes rapid and complete loss of oligo-Biotech, AL, USA) or Alexa Fluor 555 secondary antidendrocyte progenitor cells. For X-irradiation rats were bodies (Invitrogen, Ely, UK). Sections were then coveranesthetized with intramuscular injection of Hypnorm slipped using vectashield with DAPI (Vector Labora-(Jenssen Pharmaceuticals, NJ), consisting of a combinatories). tion of fentanyl citrate (0.0785 mg/kg) and fluanisone (2.5 mg/kg). When the animals were anesthetized they RESULTS were secured in lateral recumbency by adhesive tape and Characterization of GFP-Expressing Rat Bone a 4-cm (craniocaudal) × 2-cm (dorsoventral) window in Marrow MSCs lead sheeting was centered on T13 and positioned in such a way to prevent X-irradiation of the abdominal
The mononuclear layer of bone marrow was isolated cavity. Following radiography to confirm positioning of by Ficoll density gradient and plated on tissue culture the lead sheet animals were then subjected to 40 Gy of plastic in media containing low-glucose DMEM and X-irradiation (225 kV) using an X-ray machine (Pantak, 10% FCS. Adherent cells were maintained in culture and UK). Two days later, 1 µl of cell suspension containing passaged when 80% confluent. The cells displayed the 5 × 10 3 cells was injected into the EB lesion site (n = 5).
typical morphology of rat MSCs (16, 27) at confluence Control rats were injected with DMEM alone (n = 3).
( Fig. 1a ) and maintained a stable phenotype over 40 population doublings with a constant doubling time of Processing of Tissue for Immunohistochemical 4-5 days. Prior to transplantation FACS analysis conand Ultrastructural Analysis firmed that 93% of cells expressed GFP (Fig. 1c) . Cells expressed the cell surface markers CD44 and CD90 as Rats were perfused with 4% paraformaldehyde in well as fibronectin (all >95%). Cells did not express phosphate buffer under deep anesthesia 3 weeks follow-CD34 and CD45 (11) (Fig. 1c ). Functional differentiaing transplantation. The length of the spinal cord contion of MSCs along osteogenic and adipogenic lineages taining the lesion was removed and cut into 1-mm transwas demonstrated using standard differentiation protoverse slices; alternate blocks were postfixed in 4% cols (16, 27) . Adipogenic differentiation was shown by glutaldehyde and embedded in TAAB resin while the immunostaining for fatty acid binding protein (FABP) others were cryoprotected in 30% sucrose solution and and the identification of lipid droplets characteristic of rapidly frozen using dry ice. Sections (20 µm) were cut adipocytes (Fig. 1e) . The presence of osteocytes was defrom the frozen blocks and mounted onto polylysinetermined by immunostaining for osteocalcin and the coated glass slides (VWR International Ltd, Lutterwidentification of calcium deposition by Alizarin red orth, UK) for immunohistochemical analysis. The resin staining (Fig. 1f ). The cells therefore displayed a phenoblocks were sectioned at 1 µm with sections stained with type consistent with multipotent MSCs. toluidine blue. Selected areas were examined by electron microscopy.
Transplanted Mesenchymal Stromal Cells Do Not Remyelinate Immunohistochemistry
All sections were blocked with 10% NGS (Sigma-Focal demyelination was induced by injection of EB into the dorsal funiculus of the adult spinal cord. In-Aldrich. Poole, UK) in Triton (0.3% in PBS) for 1 h and then incubated overnight at 4°C with primary antibody tralesional injection of MSCs (5000 cells/µl DMEM, n = 5) or control injections (DMEM alone, n = 3) were dorsal funiculus lesion in all five rats. Migration of GFP+ cells beyond the demyelinated area into adjacent performed 2 days after X-irradiation. Animals were sacrificed 3 weeks after transplantation with adjacent normal white matter was observed in three of the five animals. Cells migrated distances of up to 150 µm in all blocks processed for preparation of frozen and plasticembedded sections.
directions from the site of injection (Fig. 3f) . Analysis of the adjacent toluidine blue semithin sections revealed Analysis of toluidine blue semithin sections of control animals (DMEM microinjection) revealed demyel-no evidence of remyelination in regions of transplanted MSCs (Fig. 2b) . Furthermore, compared to control inated axons clumped together and separated by macrophages containing myelin debris. As expected, no treated lesions ( Fig. 2a) there was considerable disruption of cytoarchitecture where transplanted MSCs were remyelination of the dorsal funiculus was seen in the control group (Fig. 2a) .
present. Electron microscopy of these regions revealed the presence of large cells with a fibroblastic appear-In MSC-transplanted animals, immunohistochemical analysis revealed GFP+ cells within the demyelinated ance, only present in transplanted lesions. These cells showed no association with demyelinated axons and cyte precursor cells (NG2), or oligodendrocytes (CNPase, MBP). there was no evidence of remyelination. Transplanted MSCs were surrounded by extensive collagen deposition DISCUSSION (Fig. 2e ).
We report that direct transplantation of multipotent Transplanted Mesenchymal Stromal Cells bone marrow MSCs into the adult demyelinated spinal Are Associated With Axonal Damage cord did not lead to remyelination. Transplanted cells In regions of high GFP immunoreactivity, intense expressed mesenchymal markers and did not express SMI32 (dephosphorylated neurofilament) staining was any markers of neuronal or glial differentiation. In addiseen, indicating the presence of axonal damage (Fig. 2f tion, transplantation of MSCs into the demyelinated spii). This pattern of strong immunoreactivity was not seen nal cord led to a number of potentially adverse effects. in control lesions. GFP expression did not colocalize Transplanted MSCs migrated beyond the lesion site into with SMI32 expression (Fig. 2i ). In these regions axons areas of normal appearing white matter and ultrastrucexpressing SMI32 appeared displaced by GFP-expresstural analysis suggested transplanted MSCs deposited ing transplanted MSCs and exhibited a dystrophic morcollagen and disrupted cellular architecture. In addition, phology (Fig. 2f) . This was not observed in control legrafted MSCs were associated with extensive axon desions. The presence of morphological changes in the generation. dorsal funiculi characteristic of Wallerian degeneration
Our results contrast with previous published reports in resin sections taken rostral to the transplant site were that demonstrated robust Schwann cell remyelination consistent with axon transection in the transplanted lefollowing bone marrow stromal cell injection into the sions (Fig. 2c) . demyelinated X-EB lesion (2). This study reported no deleterious effects of such transplants. A potential expla-Transplanted Cells Express Mesenchymal Markers nation for this important difference is the distinct culture and Do Not Express Neuronal or Glial Markers methodologies used to generate MSCs. Although there are some minor interspecies differences in the properties We examined whether the transplanted MSCs expressed markers of mesenchymal, neuronal, or glial cell and characterization of rat and human MSCs (16), we adopted and followed the key principles and recommen-lineages by immunohistochemistry. GFP+ cells strongly expressed fibronectin, a marker of mesenchymal stromal dations of the ISCT when characterizing MSCs. This included demonstration of functional differentiation of cells ( Fig. 3a-c, colocalization Fig. 3d ). GFP+ cells did not express markers for astrocytes (GFAP, Fig. 3e-h) ,
MSCs into cells of a mesenchymal lineage, which has not been demonstrated by previous studies (2). In addi-neurons (SMI31), Schwann cells (p75, S100), oligodendro- tion, Akiyama and coworkers cultured bone marrow servation that MSCs migrate and selectively home to sites of inflammation and tissue damage, both in animal stromal cells in a media specialized for the growth of neural precursor cells, which contained serum, EGF, models and patients with severe tissue damage (29). There is considerable interest in developing MSC-FGF, and proprietary neural survival factors (2). In contrast, MSCs in the present study were grown according based treatments for patients with multiple sclerosis, and experimental trials are currently recruiting patients for to established protocols using low-glucose DMEM and 10% fetal calf serum. Similar protocols are used in virtu-this purpose (12, 32) . The rationale for the use of MSCs in the treatment of multiple sclerosis is varied and in-ally all clinical studies using human MSCs (10, 13, 21) . It is possible that prior in vitro treatment with media cludes remyelinating, neuroprotective, and immunomodulatory mechanisms of action (5,32, 35, 36) . A key ques-specialized for the growth of neuronal cells may alter initial adherence, selection, and growth of colony-form-tion is whether MSCs should be delivered focally (by intralesional injection) or systemically (by intravenous ing cells from the bone marrow, allowing the generation of cells with a myelinating phenotype. Further study of infusion). The safety of intraspinal injection of MSCs is unknown and to our knowledge there are no clinical case the consequences of such differences in culture methodology will be of considerable interest.
reports of direct intraspinal injection of MSCs into a demyelinated lesion. There has been a small uncontrolled The behavior of transplanted MSCs is similar to that observed when Schwann cell cultures contaminated with trial of intraspinal injection of autologous MSCs in patients with motor neuron disease (23) . One recent report fibroblasts were injected into the X-EB lesion (7) . In these studies, when significant numbers of contaminat-of intrathecal delivery of GFP rodent MSCs in a model of multiple sclerosis reports an abnormal cellular reac-ing fibroblasts were present in transplanted human Schwann cells cultures, a failure of remyelination was observed tion surrounding transplanted cells, despite efficacy of the cellular therapy in improving the functional outcome and was associated with deposition of large amounts of collagen by fibroblasts and extensive axonal degenera-of the animals with EAE (28). Other preclinical reports of direct injection of MSCs into the nondemyelinated tion. Undifferentiated MSCs have a fibroblastic morphology and are derived from colony-forming unit fibro-spinal cord do not report adverse events (3, 12, 22, 24) . This study cautions against direct focal injection of blasts (CFU-F) from the bone marrow. MSCs may therefore behave in a similar manner to fibroblasts in MSCs into demyelinated lesions as a strategy for remyelination. Further studies are required to examine the the X-EB model of demyelination.
Although this is a small study, our results reported factors affecting the in vivo behavior of MSCs in experimental models of demyelination. Such studies should in-here are representative of a variety of different cells with mesenchymal characteristics that we have transplanted clude careful and systematic analysis of the effects of minor alterations in cell culture technique and reagents into the X-EB lesion. These include (i) human bone marrow-derived MSCs, (ii) cells with MSC features de-on both the in vitro and in vivo behavior of these cells. rived from human dermis (18) , and (iii) rat bone marrow stromal cells cultured in neural progenitor medium. In REFERENCES all cases we have observed a failure of remyelination,
